REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug aims to shrink recurrent brain tumors by blocking key growth enzyme
Disease control OngoingThis trial tests the drug savolitinib in children and adults whose brain tumors (medulloblastoma, high-grade glioma, or DIPG) have come back or not responded to treatment. The drug works by blocking an enzyme that some tumor cells need to grow. The study aims to find the safest d…
Matched conditions: REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could an immune booster help kids fight deadly brain cancer?
Disease control OngoingThis early-stage trial is testing the safety and potential benefit of pembrolizumab, an immunotherapy drug, in 71 children whose brain tumors (like DIPG, high-grade gliomas, or medulloblastoma) have come back or not responded to standard treatments. The drug works by helping the …
Matched conditions: REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC